Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Leukocyte transendothelial migration	10/114	5.496930008346214E-5	0.013742325020865536	0	0	5.171381648654376	50.72471584136727	ITGB1;RAP1A;PTK2B;PIK3R2;THY1;ITGAL;MYL9;ACTB;RAPGEF4;GNAI2
Proteoglycans in cancer	13/205	1.3164585701167512E-4	0.01645573212645939	0	0	3.6553096064814814	32.661635701118676	ITGB1;ARAF;PIK3R2;NUDT16L1;HSPG2;ACTB;NRAS;PLAU;SDC1;FAS;MAPK1;FLNB;SOS1
Non-small cell lung cancer	7/72	3.858295717444737E-4	0.024849445665711654	0	0	5.755947877259353	45.242411155507114	NRAS;ARAF;MAPK1;PIK3R2;POLK;SOS1;STK4
Prostate cancer	8/97	4.6317506317757165E-4	0.024849445665711654	0	0	4.811574572879791	36.940408940940316	NRAS;ZEB1;CREB3L4;PLAU;ARAF;MAPK1;PIK3R2;SOS1
Alzheimer disease	17/369	6.089650545239374E-4	0.024849445665711654	0	0	2.6148732763023492	19.35986716602005	CSNK1A1;ARAF;NDUFA1;NDUFB1;PIK3R2;NDUFC1;CSNK1E;HSD17B10;NCSTN;NRAS;TUBB6;PSMD7;PSMD2;NDUFAB1;DVL2;FAS;MAPK1
Endometrial cancer	6/58	7.223086841654717E-4	0.024849445665711654	0	0	6.154370153007755	44.514916085822335	NRAS;ARAF;MAPK1;PIK3R2;POLK;SOS1
FoxO signaling pathway	9/131	7.951822613027729E-4	0.024849445665711654	0	0	3.953003963249865	28.21234898294151	PRKAA1;NRAS;ARAF;MAPK1;PIK3R2;CSNK1E;STK4;SOS1;PRKAB1
Natural killer cell mediated cytotoxicity	9/131	7.951822613027729E-4	0.024849445665711654	0	0	3.953003963249865	28.21234898294151	NRAS;ARAF;MAPK1;PTK2B;FAS;PIK3R2;ULBP2;ITGAL;SOS1
Hepatocellular carcinoma	10/168	0.0012526212825009623	0.03466614961651002	0	0	3.394532203508038	22.68401880856531	SMARCC1;NRAS;CSNK1A1;ARAF;DVL2;MAPK1;PIK3R2;POLK;SOS1;ACTB
Thermogenesis	12/232	0.0014409689794264997	0.03466614961651002	0	0	2.932309242004533	19.18445577976502	SMARCC1;NRAS;PRKAA1;CREB3L4;NDUFAB1;NDUFA1;ACSL5;NDUFB1;NDUFC1;SOS1;PRKAB1;ACTB
Acute myeloid leukemia	6/67	0.0015480364020380452	0.03466614961651002	0	0	5.243936212980747	33.932294581020194	NRAS;ARAF;MAPK1;PIK3R2;SOS1;RUNX1T1
Breast cancer	9/147	0.0017863112134261243	0.03466614961651002	0	0	3.4918179646440515	22.094836292378425	NRAS;CSNK1A1;NCOA3;ARAF;DVL2;MAPK1;PIK3R2;POLK;SOS1
Renal cell carcinoma	6/69	0.0018026397800585208	0.03466614961651002	0	0	5.0769430387959	32.07868055218124	NRAS;RAP1A;ARAF;MAPK1;PIK3R2;SOS1
Regulation of actin cytoskeleton	11/218	0.0027187529538829458	0.045978913795771334	0	0	2.8507753489737637	16.841189071053254	ITGB1;NRAS;ITGA1;ARAF;MAPK1;PIK3R2;ARHGEF7;ITGAL;SOS1;MYL9;ACTB
Glioma	6/75	0.00275873482774628	0.045978913795771334	0	0	4.63404809856652	27.308367129868873	NRAS;ARAF;MAPK1;PIK3R2;POLK;SOS1
Chronic myeloid leukemia	6/76	0.002949140453524093	0.04608031958631396	0	0	4.5676138575321135	26.612021516752137	NRAS;ARAF;MAPK1;PIK3R2;POLK;SOS1
Hepatitis B	9/162	0.003442348700186874	0.05062277500274815	0	0	3.1470588235294117	17.84886284827247	NRAS;CREB3L4;ARAF;MAPK1;PTK2B;FAS;PIK3R2;SOS1;HSPG2
Colorectal cancer	6/86	0.005433638716749173	0.07277532169742511	0	0	3.994618528610354	20.832519863152537	NRAS;ARAF;MAPK1;PIK3R2;POLK;SOS1
Gap junction	6/88	0.006072866965957887	0.07277532169742511	0	0	3.8967900578188344	19.88892212325239	TJP1;TUBB6;NRAS;MAPK1;SOS1;GNAI2
Rap1 signaling pathway	10/210	0.0062317072386	0.07277532169742511	0	0	2.6758953168044077	13.588477250294352	ITGB1;NRAS;RAP1A;MAGI2;MAPK1;PIK3R2;ITGAL;ACTB;RAPGEF4;GNAI2
Hypertrophic cardiomyopathy	6/90	0.0067651830679624995	0.07277532169742511	0	0	3.8036200856364344	19.002756459989797	ITGB1;PRKAA1;ITGA1;CACNG1;PRKAB1;ACTB
GnRH secretion	5/64	0.0068090229174045695	0.07277532169742511	0	0	4.50626381724392	22.484033268080374	HCN3;NRAS;TRPC1;MAPK1;PIK3R2
Gastric cancer	8/149	0.0069467704579854635	0.07277532169742511	0	0	3.029010006800738	15.052599831585647	NRAS;CSNK1A1;ARAF;DVL2;MAPK1;PIK3R2;POLK;SOS1
Neurotrophin signaling pathway	7/119	0.006986430882952811	0.07277532169742511	0	0	3.3324795081967213	16.541713316657344	YWHAE;NRAS;RAP1A;MAPK1;PIK3R2;NFKBIE;SOS1
Oxytocin signaling pathway	8/154	0.008408986771708395	0.08116591415880622	0	0	2.924526177519234	13.974714662821485	PRKAA1;NRAS;MAPK1;CACNG1;PRKAB1;MYL9;ACTB;GNAI2
Non-alcoholic fatty liver disease	8/155	0.008727154303628717	0.08116591415880622	0	0	2.9044823408815583	13.771068390588216	PRKAA1;NDUFAB1;NDUFA1;NDUFB1;FAS;PIK3R2;NDUFC1;PRKAB1
Fc epsilon RI signaling pathway	5/68	0.008765918729151072	0.08116591415880622	0	0	4.219289164941339	19.986283118109064	NRAS;ALOX5AP;MAPK1;PIK3R2;SOS1
Phosphatidylinositol signaling system	6/97	0.009640853555793168	0.08607904960529615	0	0	3.5097763272150195	16.291488933154614	INPP1;DGKA;SACM1L;INPP5E;PIK3R2;PI4KB
Melanoma	5/72	0.01108058034913696	0.09552224438911174	0	0	3.9665801427644385	17.85976993061627	NRAS;ARAF;MAPK1;PIK3R2;POLK
Longevity regulating pathway	6/102	0.012166758809980267	0.10055222017756525	0	0	3.3261239782016347	14.665039387986859	PRKAA1;NRAS;CREB3L4;EHMT1;PIK3R2;PRKAB1
Focal adhesion	9/201	0.013417966606856149	0.10055222017756525	0	0	2.5027901785714284	10.78993060446119	ITGB1;RAP1A;ITGA1;MAPK1;PIK3R2;FLNB;SOS1;MYL9;ACTB
Vibrio cholerae infection	4/50	0.013968181153853336	0.10055222017756525	0	0	4.614351360904913	19.707771508913073	TJP1;ATP6V0A2;KDELR2;ACTB
Tight junction	8/169	0.01418500319971162	0.10055222017756525	0	0	2.650012762698885	11.277314773209158	ITGB1;TJP1;PRKAA1;RAP1A;ARHGEF2;PRKAB1;MYL9;ACTB
Apelin signaling pathway	7/137	0.014479519705569396	0.10055222017756525	0	0	2.8684110970996217	12.147778542508549	HDAC5;PRKAA1;NRAS;MAPK1;NRF1;PRKAB1;GNAI2
Estrogen signaling pathway	7/137	0.014479519705569396	0.10055222017756525	0	0	2.8684110970996217	12.147778542508549	NRAS;CREB3L4;NCOA3;MAPK1;PIK3R2;SOS1;GNAI2
Insulin signaling pathway	7/137	0.014479519705569396	0.10055222017756525	0	0	2.8684110970996217	12.147778542508549	PRKAA1;NRAS;ARAF;MAPK1;PIK3R2;SOS1;PRKAB1
B cell receptor signaling pathway	5/81	0.017736512582253432	0.11791148912236733	0	0	3.495244565217391	14.093280141655985	NRAS;MAPK1;PIK3R2;SOS1;NFKBIE
Signaling pathways regulating pluripotency of stem cells	7/143	0.017922546346599837	0.11791148912236733	0	0	2.741019768563163	11.0235476533833	ZFHX3;NRAS;DVL2;HESX1;MAPK1;PIK3R2;DUSP9
Circadian rhythm	3/31	0.019657717727273094	0.12601101107226342	0	0	5.675386100386101	22.30021093838108	PRKAA1;CSNK1E;PRKAB1
Phospholipase D signaling pathway	7/148	0.02120210851506168	0.13044657126409454	0	0	2.64314227027865	10.185757484591376	NRAS;DGKA;MAPK1;PTK2B;PIK3R2;SOS1;RAPGEF4
ErbB signaling pathway	5/85	0.021393237687311505	0.13044657126409454	0	0	3.3198029891304346	12.763581493505104	NRAS;ARAF;MAPK1;PIK3R2;SOS1
MAPK signaling pathway	11/294	0.022683037716008787	0.13501808164290946	0	0	2.0770357066161687	7.863943548230135	NRAS;RAP1A;ARAF;FLT3LG;FAS;MAPK1;FLNB;CACNG1;STK4;SOS1;DUSP9
RNA transport	8/186	0.023732152640915955	0.13740199706112569	0	0	2.3948283823303065	8.958872165751256	EEF1A1;EIF2B4;MAGOH;NUP62;RNPS1;THOC5;EIF1B;SRRM1
Growth hormone synthesis, secretion and action	6/119	0.02418275148275812	0.13740199706112569	0	0	2.823274095150828	10.50855268982512	NRAS;CREB3L4;MAPK1;PIK3R2;SOS1;GNAI2
Long-term depression	4/60	0.02561196369462922	0.13946393230208207	0	0	3.788424312814557	13.883422307285484	NRAS;ARAF;MAPK1;GNAI2
mTOR signaling pathway	7/154	0.0256613635435831	0.13946393230208207	0	0	2.53447827218319	9.283207894844985	PRKAA1;NRAS;MAPKAP1;DVL2;MAPK1;PIK3R2;SOS1
Hepatitis C	7/157	0.028114991940830912	0.14954782947250486	0	0	2.4834061930783244	8.869366819427848	YWHAE;NRAS;ARAF;MAPK1;FAS;PIK3R2;SOS1
Platelet activation	6/124	0.028841509419198906	0.15021619489166096	0	0	2.702951092227405	9.584501396522496	ITGB1;RAP1A;MAPK1;PIK3R2;ACTB;GNAI2
Thyroid cancer	3/37	0.03132328301091346	0.15950493793971549	0	0	4.67241653418124	16.182417482722215	NRAS;MAPK1;POLK
Pathogenic Escherichia coli infection	8/197	0.031900987587943096	0.15950493793971549	0	0	2.25417119663695	7.765886465213853	TJP1;ITGB1;TUBB6;ABI1;FAS;MAPK1;ARHGEF2;ACTB
Prion disease	10/273	0.03282492611248062	0.16063885671516387	0	0	2.0283023808775624	6.929831203130691	TUBB6;PSMD7;CREB3L4;PSMD2;NDUFAB1;NDUFA1;NDUFB1;MAPK1;PIK3R2;NDUFC1
Pathways of neurodegeneration	15/475	0.03384354006071139	0.16063885671516387	0	0	1.745840417779937	5.911428116398482	CSNK1A1;ARAF;NDUFA1;NDUFB1;NDUFC1;CSNK1E;HSD17B10;NRAS;TUBB6;PSMD7;PSMD2;NDUFAB1;DVL2;FAS;MAPK1
Relaxin signaling pathway	6/129	0.03405543762361474	0.16063885671516387	0	0	2.5924104472652356	8.761739557099945	NRAS;CREB3L4;MAPK1;PIK3R2;SOS1;GNAI2
Long-term potentiation	4/67	0.03642271150113604	0.16603190211768704	0	0	3.3662838215683744	11.15102641537702	NRAS;RAP1A;ARAF;MAPK1
Choline metabolism in cancer	5/98	0.036527018465891146	0.16603190211768704	0	0	2.853845254791959	9.445380373373348	NRAS;DGKA;MAPK1;PIK3R2;SOS1
Progesterone-mediated oocyte maturation	5/100	0.039316550142633036	0.17109546410147358	0	0	2.7934782608695654	9.040002168062788	CDC23;ARAF;MAPK1;PIK3R2;GNAI2
Adipocytokine signaling pathway	4/69	0.03992611711744312	0.17109546410147358	0	0	3.2623723160308526	10.507202788497663	PRKAA1;ACSL5;NFKBIE;PRKAB1
Bladder cancer	3/41	0.040714953015425534	0.17109546410147358	0	0	4.17972972972973	13.379983028311308	NRAS;ARAF;MAPK1
Melanogenesis	5/101	0.040758661874073954	0.17109546410147358	0	0	2.7642379981884058	8.845801808022562	NRAS;CREB3L4;DVL2;MAPK1;GNAI2
Central carbon metabolism in cancer	4/70	0.041747293240759556	0.17109546410147358	0	0	3.2127781883879445	10.204171187665954	LDHA;NRAS;MAPK1;PIK3R2
Prolactin signaling pathway	4/70	0.041747293240759556	0.17109546410147358	0	0	3.2127781883879445	10.204171187665954	NRAS;MAPK1;PIK3R2;SOS1
Yersinia infection	6/137	0.04359788075848473	0.17579790628421263	0	0	2.433096907044949	7.622276394562145	ITGB1;MAPK1;PTK2B;PIK3R2;ARHGEF7;ACTB
T cell receptor signaling pathway	5/104	0.04527552790494989	0.17966479327361068	0	0	2.6800614844093107	8.294759782590699	NRAS;MAPK1;PIK3R2;NFKBIE;SOS1
Human papillomavirus infection	11/331	0.047087226462553346	0.18264836465380338	0	0	1.8333649861878454	5.6023115010261355	ITGB1;NRAS;CREB3L4;CSNK1A1;ITGA1;ATP6V0A2;DVL2;FAS;MAPK1;PIK3R2;SOS1
Inositol phosphate metabolism	4/73	0.04748857480998888	0.18264836465380338	0	0	3.0726208711362477	9.363093502309354	INPP1;SACM1L;INPP5E;PI4KB
Insulin resistance	5/108	0.05174505292605219	0.19600398835625832	0	0	2.5754537779653863	7.627016931190767	PRKAA1;CREB3L4;PIK3R2;PRKAB1;OGT
Pancreatic cancer	4/76	0.05364506737324913	0.19876631503915085	0	0	2.944143330322192	8.612696076292075	ARAF;MAPK1;PIK3R2;POLK
Proteasome	3/46	0.05421205758045559	0.19876631503915085	0	0	3.692771841609051	10.763883132126807	PSMD7;PSMD2;PSME2
Axon guidance	7/182	0.05485950295080563	0.19876631503915085	0	0	2.1259016393442622	6.171449630250001	ITGB1;NRAS;TRPC1;MAPK1;PIK3R2;MYL9;GNAI2
Arrhythmogenic right ventricular cardiomyopathy	4/77	0.055788962950133636	0.1992462962504773	0	0	2.903664105134202	8.38049501879948	ITGB1;ITGA1;CACNG1;ACTB
Nucleotide excision repair	3/47	0.05713803626561698	0.19990369735590638	0	0	3.608660933660934	10.329016962091995	ERCC2;ERCC6;GTF2H3
Retrograde endocannabinoid signaling	6/148	0.059214648467773426	0.19990369735590638	0	0	2.2433511148635685	6.341025588755706	NDUFAB1;NDUFA1;NDUFB1;MAPK1;NDUFC1;GNAI2
Alcoholism	7/186	0.06023787515488427	0.19990369735590638	0	0	2.0779680678938854	5.8379556360197835	HDAC5;NRAS;CREB3L4;ARAF;MAPK1;SOS1;GNAI2
Cholinergic synapse	5/113	0.06055295487057336	0.19990369735590638	0	0	2.45559078099839	6.886058548677233	NRAS;CREB3L4;MAPK1;PIK3R2;GNAI2
Serotonergic synapse	5/113	0.06055295487057336	0.19990369735590638	0	0	2.45559078099839	6.886058548677233	NRAS;TRPC1;ARAF;MAPK1;GNAI2
Human cytomegalovirus infection	8/225	0.06080728485055976	0.19990369735590638	0	0	1.9604822927845464	5.489439975738291	NRAS;CREB3L4;FAS;MAPK1;PTK2B;PIK3R2;SOS1;GNAI2
Huntington disease	10/306	0.06192550386628165	0.19990369735590638	0	0	1.7991028218300946	5.004785909440804	TUBB6;PSMD7;CREB3L4;PSMD2;NDUFAB1;NDUFA1;NDUFB1;NDUFC1;NRF1;AP2M1
Adrenergic signaling in cardiomyocytes	6/150	0.06236995357504279	0.19990369735590638	0	0	2.211966394187103	6.137480406640031	CREB3L4;MAPK1;CACNG1;SCN4B;RAPGEF4;GNAI2
Ether lipid metabolism	3/49	0.06320910910428758	0.20002882627939106	0	0	3.451410105757932	9.530402390721358	UGT8;PLA2G12A;PAFAH1B1
Chemokine signaling pathway	7/192	0.06889287841668834	0.21290768747885744	0	0	2.0099542165115936	5.377034479484942	NRAS;RAP1A;MAPK1;PTK2B;PIK3R2;SOS1;GNAI2
PI3K-Akt signaling pathway	11/354	0.06903924870402302	0.21290768747885744	0	0	1.7083903806194933	4.566664353904325	ITGB1;YWHAE;NRAS;PRKAA1;CREB3L4;MAGI2;ITGA1;FLT3LG;MAPK1;PIK3R2;SOS1
Ras signaling pathway	8/232	0.06998314895817126	0.21290768747885744	0	0	1.89853228962818	5.049148133754382	NRAS;PLA2G12A;RAP1A;FLT3LG;MAPK1;PIK3R2;STK4;SOS1
Cushing syndrome	6/155	0.07068535224298067	0.21290768747885744	0	0	2.137190717407604	5.662522944379692	RAP1A;CREB3L4;DVL2;MAPK1;PDE8A;GNAI2
Thyroid hormone signaling pathway	5/121	0.07630369691780317	0.2270943360648904	0	0	2.2853026611694154	5.8801611948841	NRAS;NCOA3;MAPK1;PIK3R2;ACTB
ECM-receptor interaction	4/88	0.0823285213922374	0.24214270997716883	0	0	2.5220028390760096	6.2975361115789585	ITGB1;ITGA1;SDC1;HSPG2
Epstein-Barr virus infection	7/202	0.08488965955192773	0.24425975993433877	0	0	1.905898837046378	4.700714587854376	PSMD7;PSMD2;FAS;PIK3R2;POLK;NFKBIE;ITGAL
PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	0.0850023964571499	0.24425975993433877	0	0	2.49220468675275	6.143473534921882	NRAS;MAPK1;PIK3R2;NFKBIE
Viral carcinogenesis	7/203	0.08659706524351549	0.2460143898963508	0	0	1.8960772833723654	4.638732885535982	YWHAE;HDAC5;NRAS;CREB3L4;MAPK1;PIK3R2;GTF2H3
Parkinson disease	8/249	0.09561510150373675	0.26698231215338847	0	0	1.7630648553401922	4.138661646880924	TUBB6;PSMD7;PSMD2;NDUFAB1;NDUFA1;NDUFB1;NDUFC1;GNAI2
GnRH signaling pathway	4/93	0.09611363237521986	0.26698231215338847	0	0	2.379708291464937	5.573810151515076	NRAS;MAPK1;PTK2B;SOS1
VEGF signaling pathway	3/59	0.09766059031609724	0.2682983250442232	0	0	2.8336389961389963	6.591773048287847	NRAS;MAPK1;PIK3R2
Oxidative phosphorylation	5/133	0.10365283493648922	0.28006019016730715	0	0	2.0697817595108696	4.691591057623189	NDUFAB1;ATP6V0A2;NDUFA1;NDUFB1;NDUFC1
Dilated cardiomyopathy	4/96	0.1048712584266554	0.28006019016730715	0	0	2.3017556262519148	5.190509095526169	ITGB1;ITGA1;CACNG1;ACTB
Arachidonic acid metabolism	3/61	0.10530263150290749	0.28006019016730715	0	0	2.7356477166821995	6.157715594827055	PLA2G12A;PTGES2;CBR3
cAMP signaling pathway	7/216	0.1105472448329944	0.2888140138210558	0	0	1.776949826130154	3.9133984485299282	RAP1A;CREB3L4;MAPK1;PIK3R2;MYL9;RAPGEF4;GNAI2
Glycerophospholipid metabolism	4/98	0.11090458130728545	0.2888140138210558	0	0	2.2525514616848294	4.95355230056513	LYPLA2;PLA2G12A;DGKA;LCAT
Fluid shear stress and atherosclerosis	5/139	0.11892045258894375	0.3064960118271746	0	0	1.9764965931213498	4.208555134633424	PRKAA1;SDC1;PIK3R2;ARHGEF2;ACTB
Chagas disease	4/102	0.12342060829997208	0.3091537908506366	0	0	2.1601681322935677	4.5194112623748675	MAPK1;FAS;PIK3R2;GNAI2
Pathways in cancer	14/531	0.12354377382125799	0.3091537908506366	0	0	1.4414637694433818	3.0143310039487594	ITGB1;NCOA3;ARAF;FLT3LG;PIK3R2;STK4;GNAI2;NRAS;DVL2;FAS;MAPK1;POLK;SOS1;RUNX1T1
Aminoacyl-tRNA biosynthesis	3/66	0.12537546175805656	0.3091537908506366	0	0	2.517889317889318	5.228252011501006	PARS2;TARS2;IARS2
SNARE interactions in vesicular transport	2/33	0.1256777124539236	0.3091537908506366	0	0	3.407703677941049	7.067694948005508	STX16;YKT6
Apoptosis	5/142	0.12693028009396978	0.3091537908506366	0	0	1.932918121231355	3.9897697700567822	NRAS;MAPK1;FAS;PIK3R2;ACTB
MicroRNAs in cancer	9/310	0.1273713618304623	0.3091537908506366	0	0	1.58751049614837	3.271300885309932	HDAC5;ZEB2;NRAS;ZEB1;PLAU;CCNG1;MAPK1;PIK3R2;SOS1
Glycolysis / Gluconeogenesis	3/67	0.12954512405221258	0.3114065482024341	0	0	2.478420608108108	5.0652126611472985	LDHA;ALDH1B1;PGK1
Parathyroid hormone synthesis, secretion and action	4/106	0.13650683393011262	0.3250162712621729	0	0	2.075030554227111	4.132175590485811	CREB3L4;ARAF;MAPK1;GNAI2
Glucagon signaling pathway	4/107	0.13986323116834368	0.3298661112460936	0	0	2.054779382745284	4.041936498116717	LDHA;PRKAA1;CREB3L4;PRKAB1
Ribosome biogenesis in eukaryotes	4/108	0.14325239312248095	0.33339830479825455	0	0	2.0349176568688763	3.954144583011709	XRN1;GNL2;UTP14A;MDN1
Amyotrophic lateral sclerosis	10/364	0.14479078340153062	0.33339830479825455	0	0	1.499821014458919	2.898352294022853	TUBB6;PSMD7;PSMD2;HNRNPA2B1;NDUFAB1;NUP62;NDUFA1;NDUFB1;NDUFC1;ACTB
HIF-1 signaling pathway	4/109	0.1466737225504949	0.33339830479825455	0	0	2.0154342495805913	3.8687161996919905	LDHA;PGK1;MAPK1;PIK3R2
Adherens junction	3/71	0.146695254111232	0.33339830479825455	0	0	2.332154213036566	4.47633200471029	TJP1;MAPK1;ACTB
Aldosterone-regulated sodium reabsorption	2/37	0.15121793295640892	0.3405809300820021	0	0	3.0176357335386985	5.700414140661188	MAPK1;PIK3R2
TNF signaling pathway	4/112	0.15712465860592964	0.35072468438823584	0	0	1.9591488507477668	3.625827702907919	CREB3L4;MAPK1;FAS;PIK3R2
Pertussis	3/76	0.16909113796178318	0.37409543796854683	0	0	2.1718622732321364	3.8600886771125063	ITGB1;MAPK1;GNAI2
Bacterial invasion of epithelial cells	3/77	0.1736844707677503	0.37757493645163104	0	0	2.1424032140248355	3.7503089886259873	ITGB1;PIK3R2;ACTB
Leishmaniasis	3/77	0.1736844707677503	0.37757493645163104	0	0	2.1424032140248355	3.7503089886259873	ITGB1;EEF1A1;MAPK1
Shigellosis	7/246	0.17743645552278833	0.3824061541439404	0	0	1.5515010174451838	2.682766706792087	ITGB1;GLMN;MAPK1;PIK3R2;ARHGEF2;MYL9;ACTB
Sphingolipid signaling pathway	4/119	0.1825211989155026	0.390002561785262	0	0	1.839236479321315	3.128337011957676	NRAS;MAPK1;PIK3R2;GNAI2
Salmonella infection	7/249	0.18492498122576423	0.3912932298632453	0	0	1.5320304385133	2.5857687002008523	TUBB6;FHOD1;ABI1;MAPK1;FLNB;MYL9;ACTB
AMPK signaling pathway	4/120	0.18625557741490475	0.3912932298632453	0	0	1.8232875432202598	3.064281728666478	PRKAA1;CREB3L4;PIK3R2;PRKAB1
Fatty acid degradation	2/43	0.191136793101962	0.39820165229575416	0	0	2.5752416014726185	4.26142201993139	ALDH1B1;ACSL5
Basal transcription factors	2/45	0.20474198143936992	0.42064362212392653	0	0	2.455212185795775	3.8939781145496144	ERCC2;GTF2H3
Human immunodeficiency virus 1 infection	6/212	0.20527408759647617	0.42064362212392653	0	0	1.5413084309938891	2.440521919130014	NRAS;FAS;MAPK1;PTK2B;PIK3R2;GNAI2
Type II diabetes mellitus	2/46	0.21158425233425465	0.43004929336230624	0	0	2.3992893898554275	3.726413137350131	MAPK1;PIK3R2
Pyruvate metabolism	2/47	0.2184485300558153	0.4404204234996276	0	0	2.345852051512429	3.568521524196586	LDHA;ALDH1B1
Amino sugar and nucleotide sugar metabolism	2/48	0.2253316244347521	0.4448288897485128	0	0	2.2947380757060825	3.41957754839715	CYB5R3;AMDHD2
Valine, leucine and isoleucine degradation	2/48	0.2253316244347521	0.4448288897485128	0	0	2.2947380757060825	3.41957754839715	ALDH1B1;HSD17B10
Human T-cell leukemia virus 1 infection	6/219	0.2259730759922445	0.4448288897485128	0	0	1.4901178186283917	2.2163109714711293	NRAS;CDC23;CREB3L4;MAPK1;PIK3R2;ITGAL
Cocaine addiction	2/49	0.2322304560093425	0.4529205550257068	0	0	2.245799162700006	3.278923047137115	CREB3L4;GNAI2
Vascular smooth muscle contraction	4/133	0.2368124378197747	0.4529205550257068	0	0	1.6384529736770237	2.360169967471696	PLA2G12A;ARAF;MAPK1;MYL9
Arginine and proline metabolism	2/50	0.23914205305357317	0.4529205550257068	0	0	2.1988993710691824	3.1459599195201573	ALDH1B1;SRM
Cysteine and methionine metabolism	2/50	0.23914205305357317	0.4529205550257068	0	0	2.1988993710691824	3.1459599195201573	LDHA;SRM
Malaria	2/50	0.23914205305357317	0.4529205550257068	0	0	2.1988993710691824	3.1459599195201573	SDC1;ITGAL
Small cell lung cancer	3/92	0.24604508589659752	0.46249076296352915	0	0	1.7799574855754632	2.4959284457885724	ITGB1;PIK3R2;POLK
Autophagy	4/137	0.25298851420426294	0.4719934966497443	0	0	1.588850174216028	2.18373345817909	PRKAA1;NRAS;MAPK1;PIK3R2
Fc gamma R-mediated phagocytosis	3/97	0.2711714725901621	0.4999036962973955	0	0	1.6848476135710178	2.1987327369650407	BIN1;MAPK1;PIK3R2
Regulation of lipolysis in adipocytes	2/55	0.27379468813138325	0.4999036962973955	0	0	1.9909474647815695	2.5790270899144234	PIK3R2;GNAI2
mRNA surveillance pathway	3/98	0.2762325322562172	0.4999036962973955	0	0	1.667027027027027	2.1446507076900203	MAGOH;RNPS1;SRRM1
Spinocerebellar ataxia	4/143	0.27765453878415625	0.4999036962973955	0	0	1.5197987951102532	1.9474361390743442	PSMD7;PSMD2;PIK3R2;PUM1
Neutrophil extracellular trap formation	5/189	0.2779464551413519	0.4999036962973955	0	0	1.4357130198487713	1.838181843855806	HDAC5;MAPK1;PIK3R2;ITGAL;ACTB
Hedgehog signaling pathway	2/56	0.2807261445776752	0.5012529157121396	0	0	1.9539782369971048	2.482286391105565	CSNK1A1;CSNK1E
AGE-RAGE signaling pathway in diabetic complications	3/100	0.2863817591195668	0.5012529157121396	0	0	1.6324881582613542	2.041311410503368	NRAS;MAPK1;PIK3R2
Fatty acid biosynthesis	1/18	0.2875279890029983	0.5012529157121396	0	0	3.1008855154965214	3.865052455901183	ACSL5
Chemical carcinogenesis	6/239	0.2883408386050711	0.5012529157121396	0	0	1.360807381506473	1.6923164318048554	NRAS;CREB3L4;MAPK1;PIK3R2;SOS1;GNAI2
Transcriptional misregulation in cancer	5/192	0.2887216794501924	0.5012529157121396	0	0	1.4124622180888164	1.7546906575978543	CCNT2;ZEB1;PLAU;POLK;RUNX1T1
Pancreatic secretion	3/102	0.296560170095694	0.5113106380960242	0	0	1.5993447993447993	1.9440118347552877	PLA2G12A;RAP1A;TRPC1
Notch signaling pathway	2/59	0.3014802154339081	0.516233245606007	0	0	1.8508535489667566	2.21926758667022	NCSTN;DVL2
C-type lectin receptor signaling pathway	3/104	0.3067596448932468	0.5209083075860362	0	0	1.5675140487021675	1.8523168576315279	NRAS;MAPK1;PIK3R2
Viral myocarditis	2/60	0.30837771809093345	0.5209083075860362	0	0	1.8188493354400967	2.1397487234956305	ITGAL;ACTB
Glycerolipid metabolism	2/61	0.315261618826316	0.5254975530035504	0	0	1.7879300105075608	2.0639013860985123	ALDH1B1;DGKA
Phagosome	4/152	0.31529853180213024	0.5254975530035504	0	0	1.4267194023291585	1.646769995739528	ITGB1;TUBB6;ATP6V0A2;ACTB
Th17 cell differentiation	3/107	0.32208124579183445	0.5289520688792433	0	0	1.5220634095634096	1.724423945548411	MAPK1;NFKBIE;IL27RA
Pantothenate and CoA biosynthesis	1/21	0.3266884228450437	0.5289520688792433	0	0	2.6353494623655913	2.948292988288519	ALDH1B1
Diabetic cardiomyopathy	5/203	0.3287915258213803	0.5289520688792433	0	0	1.3332372639437857	1.4830016579112306	NDUFAB1;NDUFA1;NDUFB1;PIK3R2;NDUFC1
Basal cell carcinoma	2/63	0.32898113664344475	0.5289520688792433	0	0	1.7291326057178207	1.9223715871396816	DVL2;POLK
Lysine degradation	2/63	0.32898113664344475	0.5289520688792433	0	0	1.7291326057178207	1.9223715871396816	ALDH1B1;EHMT1
Endocytosis	6/252	0.33066865720699323	0.5289520688792433	0	0	1.2880308367116369	1.4253844365887909	RAB31;BIN1;EPS15;STAM2;AP2M1;CHMP5
Cellular senescence	4/156	0.33218189925616476	0.5289520688792433	0	0	1.3888888888888888	1.5306563483005664	LIN54;NRAS;MAPK1;PIK3R2
Histidine metabolism	1/22	0.3392588622936849	0.5368019973001343	0	0	2.5097286226318483	2.7129962053839023	ALDH1B1
Cortisol synthesis and secretion	2/65	0.3426245483579921	0.5387178433301764	0	0	1.6740683694861593	1.7931281831418375	CREB3L4;PDE8A
Toxoplasmosis	3/112	0.34761515171493546	0.5431486745545866	0	0	1.4518720555417803	1.534134105582318	ITGB1;MAPK1;GNAI2
Protein export	1/23	0.35159523411802535	0.5459553324814058	0	0	2.3955278592375366	2.503984587997537	SPCS1
JAK-STAT signaling pathway	4/162	0.3575788599485396	0.5487845603342694	0	0	1.3357346231690166	1.3736686234558582	PIK3R2;SOS1;STAM2;IL27RA
Glutamatergic synapse	3/114	0.35780753333794363	0.5487845603342694	0	0	1.4255661066471876	1.4651398980688524	TRPC1;MAPK1;GNAI2
Hippo signaling pathway	4/163	0.3618134009151038	0.551544818468146	0	0	1.3272655997000222	1.3493336030333298	YWHAE;DVL2;CSNK1E;ACTB
Lipid and atherosclerosis	5/215	0.37306764041685414	0.5633485256791653	0	0	1.2562758799171843	1.2386824072946057	NRAS;RAP1A;FAS;MAPK1;PIK3R2
alpha-Linolenic acid metabolism	1/25	0.37558308189493844	0.5633485256791653	0	0	2.195676523297491	2.1501723910533883	PLA2G12A
Epithelial cell signaling in Helicobacter pylori infection	2/70	0.37631681515368237	0.5633485256791653	0	0	1.5505787220548597	1.5154176390594578	TJP1;ATP6V0A2
cGMP-PKG signaling pathway	4/167	0.37873823401707146	0.563598562525404	0	0	1.2944286498079705	1.2567737047775558	CREB3L4;MAPK1;MYL9;GNAI2
p53 signaling pathway	2/73	0.3961909538607469	0.5845451841912969	0	0	1.4848335294787594	1.3747464529643174	CCNG1;FAS
Collecting duct acid secretion	1/27	0.3986857843817535	0.5845451841912969	0	0	2.026571546732837	1.8635980678980872	ATP6V0A2
Influenza A	4/172	0.39982890598684706	0.5845451841912969	0	0	1.255581365337463	1.1510147392008294	MAPK1;FAS;PIK3R2;ACTB
Gastric acid secretion	2/76	0.4157694405300906	0.6043160472821083	0	0	1.424419028192613	1.250104897612391	ACTB;GNAI2
Linoleic acid metabolism	1/29	0.4209359186555416	0.6075765340032555	0	0	1.8816244239631337	1.628121950824262	PLA2G12A
Lysosome	3/128	0.428206929933285	0.6075765340032555	0	0	1.2649945945945946	1.072903545057586	SCARB2;ATP6V0A2;MCOLN1
Synaptic vesicle cycle	2/78	0.42864378099285716	0.6075765340032555	0	0	1.3867924528301887	1.1747921763297626	ATP6V0A2;AP2M1
Ascorbate and aldarate metabolism	1/30	0.431751124803402	0.6075765340032555	0	0	1.8166481275491286	1.5258135836281974	ALDH1B1
beta-Alanine metabolism	1/30	0.431751124803402	0.6075765340032555	0	0	1.8166481275491286	1.5258135836281974	ALDH1B1
Oocyte meiosis	3/129	0.4331428668817994	0.6075765340032555	0	0	1.254890604890605	1.0499514822445197	YWHAE;CDC23;MAPK1
RNA degradation	2/79	0.43502479834633095	0.6075765340032555	0	0	1.3687121503833095	1.1392506267855058	XRN1;CNOT3
Propanoate metabolism	1/34	0.4730343822398897	0.6569921975554023	0	0	1.5961225154773542	1.1948368901562165	LDHA
Insulin secretion	2/86	0.4785714765040778	0.6610103266630909	0	0	1.2542035682197408	0.9242849471770439	CREB3L4;RAPGEF4
Kaposi sarcoma-associated herpesvirus infection	4/193	0.4864686228919676	0.6682261303461093	0	0	1.114867868255402	0.8033546937896089	NRAS;FAS;MAPK1;PIK3R2
African trypanosomiasis	1/37	0.5020213666611978	0.6858215391546417	0	0	1.4628882915173238	1.008094749872829	FAS
Morphine addiction	2/91	0.5083946023328113	0.6907535357782763	0	0	1.1834398376692208	0.8005939219878194	PDE8A;GNAI2
Allograft rejection	1/38	0.511325859476498	0.6909808911844567	0	0	1.4232781168265038	0.9546612381464611	FAS
Th1 and Th2 cell differentiation	2/92	0.5142245886300243	0.6911620814919681	0	0	1.170230607966457	0.7783147205792756	MAPK1;NFKBIE
Rheumatoid arthritis	2/93	0.5200088006917799	0.6920970201146887	0	0	1.1573116910044134	0.7567771591382988	ATP6V0A2;ITGAL
Various types of N-glycan biosynthesis	1/39	0.5204569591262459	0.6920970201146887	0	0	1.385752688172043	0.9049631403285971	STT3A
Cell adhesion molecules	3/148	0.5234003877776087	0.6923285552613871	0	0	1.0893942218080148	0.7052831313451359	ITGB1;SDC1;ITGAL
Ferroptosis	1/41	0.5382118101831853	0.704709379852988	0	0	1.3163306451612904	0.8154709114512388	ACSL5
Circadian entrainment	2/97	0.5426818381188413	0.704709379852988	0	0	1.108355795148248	0.6774626005997886	MAPK1;GNAI2
Graft-versus-host disease	1/42	0.5468418289019428	0.704709379852988	0	0	1.2841594544977708	0.7751130984366762	FAS
Tryptophan metabolism	1/42	0.5468418289019428	0.704709379852988	0	0	1.2841594544977708	0.7751130984366762	ALDH1B1
Hematopoietic cell lineage	2/99	0.5537365676659192	0.704709379852988	0	0	1.0853919470920055	0.6415385099089126	ITGA1;FLT3LG
Fat digestion and absorption	1/43	0.5553109913241545	0.704709379852988	0	0	1.2535202252944189	0.7373544132873274	PLA2G12A
Porphyrin and chlorophyll metabolism	1/43	0.5553109913241545	0.704709379852988	0	0	1.2535202252944189	0.7373544132873274	CPOX
Type I diabetes mellitus	1/43	0.5553109913241545	0.704709379852988	0	0	1.2535202252944189	0.7373544132873274	FAS
Vasopressin-regulated water reabsorption	1/44	0.5636222877632737	0.7116443027314062	0	0	1.2243060765191298	0.7019815435499297	CREB3L4
Ribosome	3/158	0.5676418789553708	0.7131179383861442	0	0	1.0185876198779424	0.5767900641816048	RPS9;RPLP1;MRPS18C
ABC transporters	1/45	0.5717786530620474	0.7147233163275593	0	0	1.196419843597263	0.6688026798384404	ABCC11
Toll-like receptor signaling pathway	2/104	0.5805401485026784	0.7201446798266425	0	0	1.0319222028434014	0.5611554946801063	MAPK1;PIK3R2
Herpes simplex virus 1 infection	9/498	0.5852020195137096	0.7201446798266425	0	0	0.9676734308636149	0.5184776426361648	ZNF254;ZNF484;EIF2B4;FAS;PIK3R2;TNFRSF14;ZNF766;HCFC2;ZNF610
Carbohydrate digestion and absorption	1/47	0.5876380587385402	0.7201446798266425	0	0	1.1442847124824684	0.6083521783191846	PIK3R2
Other types of O-glycan biosynthesis	1/47	0.5876380587385402	0.7201446798266425	0	0	1.1442847124824684	0.6083521783191846	OGT
Wnt signaling pathway	3/166	0.6011669627534182	0.7316888555880935	0	0	0.968197645498259	0.4926989107434134	CSNK1A1;DVL2;CSNK1E
Sphingolipid metabolism	1/49	0.6029116170045891	0.7316888555880935	0	0	1.0964941756272402	0.554809238271075	UGT8
Cholesterol metabolism	1/50	0.6103354800854534	0.7335762981796314	0	0	1.0740618828176431	0.530314301480394	LCAT
N-Glycan biosynthesis	1/50	0.6103354800854534	0.7335762981796314	0	0	1.0740618828176431	0.530314301480394	STT3A
Protein processing in endoplasmic reticulum	3/171	0.6212349250343937	0.741533730842867	0	0	0.9391409266409266	0.4470742509513851	SSR2;STT3A;CKAP4
Coronavirus disease	4/232	0.6312455889097586	0.741533730842867	0	0	0.9223125564588979	0.4243193787666203	RPS9;RPLP1;MAPK1;PIK3R2
Autoimmune thyroid disease	1/53	0.6317867386781226	0.741533730842867	0	0	1.0119416873449132	0.4646870437796267	FAS
Endocrine and other factor-regulated calcium reabsorption	1/53	0.6317867386781226	0.741533730842867	0	0	1.0119416873449132	0.4646870437796267	AP2M1
Glycosaminoglycan biosynthesis	1/53	0.6317867386781226	0.741533730842867	0	0	1.0119416873449132	0.4646870437796267	EXT1
Fanconi anemia pathway	1/54	0.6386721379430715	0.7461123106811584	0	0	0.9927977277338202	0.4451348025314122	POLK
Glutathione metabolism	1/57	0.658567354150979	0.7622307339710406	0	0	0.9394681259600615	0.39240501243350356	SRM
Legionellosis	1/57	0.658567354150979	0.7622307339710406	0	0	0.9394681259600615	0.39240501243350356	EEF1A1
Cell cycle	2/124	0.6757947469922582	0.7785653767191913	0	0	0.8618708850691529	0.3377377908877057	YWHAE;CDC23
Steroid hormone biosynthesis	1/61	0.6834050131438923	0.7837213453485004	0	0	0.8766577060931899	0.3337151882746526	HSD17B6
Osteoclast differentiation	2/127	0.6884613588520531	0.7859147932101063	0	0	0.8410566037735849	0.3139631383436735	MAPK1;PIK3R2
Purine metabolism	2/129	0.6966781921900999	0.7916797638523863	0	0	0.8277267228388904	0.2991666592009929	IMPDH2;PDE8A
Dopaminergic synapse	2/132	0.7086668887828528	0.8016593764511909	0	0	0.8085009330292349	0.27842321997329916	CREB3L4;GNAI2
Mitophagy	1/68	0.7226128649485254	0.8086708413931455	0	0	0.784785748675975	0.25496249421118644	NRAS
Retinol metabolism	1/68	0.7226128649485254	0.8086708413931455	0	0	0.784785748675975	0.25496249421118644	HSD17B6
Amphetamine addiction	1/69	0.727803757253831	0.8086708413931455	0	0	0.7732052498418722	0.2456657343890114	CREB3L4
Renin secretion	1/69	0.727803757253831	0.8086708413931455	0	0	0.7732052498418722	0.2456657343890114	GNAI2
Measles	2/139	0.73510687296283	0.8131713196491481	0	0	0.7669152222244083	0.2360100187946245	FAS;PIK3R2
PPAR signaling pathway	1/74	0.7523405154517361	0.8285688496164494	0	0	0.7200618647812638	0.2049053006112252	ACSL5
Thyroid hormone synthesis	1/75	0.7569764900985168	0.8300180812483737	0	0	0.7102949723917465	0.1977625158396116	CREB3L4
Metabolism of xenobiotics by cytochrome P450	1/76	0.7615259109579747	0.8313601648012825	0	0	0.7007885304659498	0.1909165769191771	CBR3
Antigen processing and presentation	1/78	0.770371507758996	0.8360596134872553	0	0	0.68251640832286	0.17805652060844454	PSME2
Spliceosome	2/150	0.7725190828622239	0.8360596134872553	0	0	0.7095140963065492	0.18312457207720306	SART1;MAGOH
Peroxisome	1/82	0.7870929952262097	0.848160555200657	0	0	0.6486791450949158	0.15529954328927598	ACSL5
Complement and coagulation cascades	1/85	0.7988320783963667	0.854128416773636	0	0	0.6254160266257041	0.14047126646932276	PLAU
Necroptosis	2/159	0.7996236670834913	0.854128416773636	0	0	0.6685322849245454	0.14949323060038552	FAS;CHMP5
Cytokine-cytokine receptor interaction	4/295	0.8032499113872796	0.854128416773636	0	0	0.7202898145819946	0.15780785703917535	TNFSF12;FAS;TNFRSF14;IL27RA
Cardiac muscle contraction	1/87	0.8062972254343124	0.854128416773636	0	0	0.6108089522380595	0.1315089011403207	CACNG1
GABAergic synapse	1/89	0.813486060326473	0.8581076585722288	0	0	0.5968658357771262	0.12320891822778202	GNAI2
IL-17 signaling pathway	1/94	0.830315304206113	0.8680616361441406	0	0	0.5646317493351832	0.10499314152033036	MAPK1
TGF-beta signaling pathway	1/94	0.830315304206113	0.8680616361441406	0	0	0.5646317493351832	0.10499314152033036	MAPK1
Staphylococcus aureus infection	1/95	0.833494836412681	0.8680616361441406	0	0	0.5585964310226493	0.10173592336017913	ITGAL
Aldosterone synthesis and secretion	1/98	0.842681312854817	0.8680616361441406	0	0	0.5412371134020618	0.0926416254443054	CREB3L4
Inflammatory mediator regulation of TRP channels	1/98	0.842681312854817	0.8680616361441406	0	0	0.5412371134020618	0.0926416254443054	PIK3R2
Viral protein interaction with cytokine and cytokine receptor	1/100	0.8485230175116167	0.8680616361441406	0	0	0.5302487237971109	0.08709763060091551	TNFRSF14
Tuberculosis	2/180	0.8520190632453151	0.8680616361441406	0	0	0.5890245010448529	0.0943301402200948	ATP6V0A2;MAPK1
Amoebiasis	1/102	0.854148359553425	0.8680616361441406	0	0	0.5196955179388907	0.08193019440685875	PIK3R2
NOD-like receptor signaling pathway	2/181	0.8541726499658342	0.8680616361441406	0	0	0.5857037449743258	0.0923197601908785	YWHAE;MAPK1
NF-kappa B signaling pathway	1/104	0.859565331594265	0.8700053963504706	0	0	0.5095521453178828	0.07710973424848758	PLAU
Drug metabolism	1/108	0.8698046758615724	0.8768192296991657	0	0	0.49040297457541954	0.06840464504605291	IMPDH2
Ubiquitin mediated proteolysis	1/140	0.9289890713790117	0.9327199511837467	0	0	0.37688558830355073	0.027760753271216736	CDC23
Calcium signaling pathway	2/240	0.9403854174058287	0.9403854174058287	0	0	0.43917189517316363	0.026993906612025158	PTK2B;MCOLN1
